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Abstract
Background: Fractures to the base of the fifth metatarsal are common, but their treatment remains controversial.
Especially for Lawrence and Botte (L&B) type II fractures, there is conflicting evidence and consequently no
consensus. Further, many authors consider displacement, articular involvement, and number of fragments an
indication for surgery, although evidence is missing. The aim of this study was to evaluate the outcome of
functional treatment for all L&B type I and II fractures. Of special interest were the influence of (1) the fracture location
(L&B type I vs. II) and (2) the fracture characteristics (displacement, intra-articular involvement, communition) on the
subjective outcome.
Methods: Retrospective registry study with a prospective follow-up. Patients with an acute, isolated, epi-metaphyseal
fracture to the fifth metatarsal bone (L&B type I and II) treated by full weightbearing with a minimum follow-up of
6 months were included. Fracture location (L&B type I and II) and characteristics (displacement <2 mm or >2 mm,
intra-articular involvement, and number of fragments) were assessed. Outcome parameters were return to work, return
to sports, VAS-FA, and SF-12. The influence of the fracture (1) location and (2) -characteristics on these parameters was
tested.
Results: Thirty-nine patients (40 ± 15 years, 56% female) were enrolled with a mean follow-up of 22 ± 10 months. L&B
type I fractures occurred in 59%, type II in 41%. Thirty-one percent of all fractures were dislocated, 74% intra-articular,
and 41% multi-fragmentary. Patients returned to work after 17 ± 12 days, to sports after 53 ± 22 days. The VAS-FA score
at the final follow-up was 96 ± 4, SF-12 PCS score 57 ± 5 and MCS score 51 ± 8. No complications were reported, no
patient required surgery. None of the assessed outcome parameters differed significantly between (1) the different
fracture locations (L&B type I vs. II) or (2) the different fracture characteristics (displacement, intra-articular involvement,
and number of fragments).
Conclusions: (1) Both, L&B I and II fractures featured excellent results with immediate full weightbearing.
Consequently, L&B type I and II fractures should be summarized as epi-metaphyseal fractures. (2) Fracture
displacement, articular involvement, and number of fragments did not influence the outcome. Therefore, functional
treatment should be recommended for all epi-metaphyseal fractures.
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Background
Treatment recommendations for fractures to the base of
the fifth metatarsal (MTV) are still a matter of debate.
Possible causes are missing evidence, various fracture
classifications, and diverging definitions for the term
“Jones fracture” [1–4]. The most widely accepted classifi-
cation was published by Lawrence and Botte [3] (L&B)
in 1993. They differentiated tuberosity avulsion fractures
(type I), Jones’ fractures (type II) and diaphyseal stress
fractures (type III) (Fig. 1). A recent systematic literature
review [5] evaluated the validity of the classification sys-
tem and treatment recommendations by Lawrence and
Botte. Overall the level of evidence available was moder-
ate. Based on this evidence a treatment-oriented adapta-
tion of the L&B classification was concluded. In
summary, L&B type I and II fractures should not be dif-
ferentiated but be summarized as epi-metaphyseal
fractures, as both apparently heal well when treated
functionally. Although these recommendations are based
on strong evidence for L&B type I fractures, only little
evidence is available for L&B type II fractures. In con-
trast, strong evidence is available in favour of surgical
treatment for L&B type III fractures (meta-diaphyseal
fractures). Furthermore, it remains largely unknown,
whether fracture characteristics, i.e. displacement, ar-
ticular involvement, number of fragments, negatively in-
fluence the outcome of functional treatment and
therefore require surgery.
Therefore, the aim of this study was to evaluate the
outcome of functional treatment for all L&B type I and
II fractures. The following two hypotheses were tested:
(1)The fracture location (L&B type I vs. II) does influence
the outcome.
(2)The fracture characteristics (displacement, intra-
articular involvement, communition) affect the
outcome.
Methods
Study design
Retrospective registry study with a prospective follow
up. The study was approved by the local ethic com-
mittee (# 541–14).
Patient selection
The study was conducted by the Division of Foot and
Ankle Surgery at the University Hospital of Munich
(LMU). Patients suffering an isolated epi-metaphyseal
fracture to the proximal fifth metatarsal bone (L&B type
I or II, Fig. 1) between Jan. 1st 2012 and Oct. 1st 2014
were identified retrospectively using the clinical and
radiographic database of the Munich University Hos-
pital. The clinical database was searched for patients di-
agnosed with a metatarsal fracture (ICD-10 Vs. 2013:
S92.3). The radiographic database was searched for the
terms: Metatarsal AND fracture AND (5 OR V) OR
Jones. All fractures were reviewed independently by two
investigators (SFB, HP). First, isolated fractures to the
fifth metatarsal were identified. Then, fractures located
distal to the fourth–fifth intermetatarsal articulation
were excluded. All remaining fractures were located at
the base of the fifth metatarsal (L&B type I and II) not
extending beyond the distal end of the fourth–fifth inter-
metatarsal articulation (L&B type III). These patients
were invited for a final follow-up visit. Only patients
meeting all inclusion criteria, including the final follow-
up visit, were enrolled. Eligibility criteria are stated in
detail in Table 1.
The results of the search strategy are outlined in Fig. 2.
The database search identified 315 fractures affecting
the fifth metatarsal bone. One hundred thirty were
Fig. 1 Illustration of the Lawrence and Botte [3] as well as the Polzer
[5] classifications. a Lawrence and Botte classification; b Polzer
classification; Reprinted from Injury, Vol 43, Polzer H, Polzer S,
Mutschler W, Prall WC, Acute fractures to the proximal fifth
metatarsal bone: development of classification and treatment
recommendations based on the current evidence, pp. 1626–1632,
Copyright (2012), with permission from Elsevier
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located at the proximal end of the fifth metatarsal. In
total 95 fractures met the inclusion criteria. Thirty-nine
patients (41%) completed the final follow-up and were
therefore included in the final analysis. Their mean age
was 40 ± 15 years, 56% were female.
Treatment regimen
Patients with acute fractures to the proximal fifth meta-
tarsal first presented to the emergency department and
were then transferred to the outpatient clinic of the Div-
ision of Foot and Ankle Surgery. After informed consent,
functional treatment was initiated. The treatment rec-
ommendations have been described in detail earlier [5].
In brief, all patients were instructed to wear shoes with a
stiff sole and conduct weightbearing as tolerated. In case
pain limited immediate full weightbearing, partial
weightbearing on crutches was conducted. Full weight-
bearing was recommended as soon as possible, the latest
after 2 weeks. In case of severe swelling the foot was
immobilized using a walker or a short leg cast for a
maximum of 2 weeks. Return to work and sports was
encouraged as soon as possible. Radiographic follow-up
was performed in case of prolonged symptoms of more
than 6 weeks only. If symptoms subsided within 6 weeks,
no radiographic follow-up was performed. This treat-
ment regimen was conducted for all epi-metaphyseal
fractures (L&B type I & II), not extending beyond the
distal end of fourth–fifth intermetatarsal articulation
(L&B type III), regardless of the number of fragments,
displacement and intraarticular involvement.
Data collection
Data were collected retrospectively based on patient re-
cords and prospectively based on a follow-up visit or
phone interview. Table 2 lists the variables collected.
Fracture classification and characteristics were assessed
on the initial radiographs by two independent investiga-
tors (SFB, HP). Disagreement was resolved by discus-
sion. Fractures were first classified per Lawrence and
Botte type I or II [3]. Then, the following fracture char-
acteristics were assessed: Displacement (none, ≤2 mm,
>2 mm), intra-articular involvement (binary), and num-
ber of fragments (two- or multiple). Fractures were clas-
sified intra-articular if the articulation between the
metatarsal and cuboid bone was affected. Finally, if avail-
able, radiographic follow-ups after 6 weeks were evalu-
ated. Patient records were screened for complications as
well as return to work and sports. In order to evaluate
the mid-term results, patient rated outcome measures
were assessed at the final follow-up visit at least 6
months after the trauma.
Outcome variables
The primary outcome parameter was return to work.
Secondary outcome parameters were return to sports,
the Visual Analog Scale Foot and Ankle (VAS-FA) [6]
and the 12-item short-form (SF-12v2). The VAS-FA was
evaluated using the developers’ analysis instrument [6].
The VAS-FA is a validated, subjective, VAS based foot
and ankle outcome score. It comprises of 20 items,
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Age≥ 18 years Age < 18 years
Isolated, traumatic, epi-metaphyseal
fractures to the proximal fifth
metatarsal (L&B type I & II)
Meta-diaphyseal- (L&B type III),
shaft-, and distal fractures to the
fifth metatarsal
Follow-up of at least 6 month Any further injuries
Non-traumatic or any pathological
fractures
Time to treatment >6 weeks
Missing initial radiographs
Fig. 2 Flow chart depicting the patient selection. MTV: Fifth
metatarsal; n = Number; L&B: Lawrence and Botte; OP: Operation
Table 2 Variables assessed based on the patient records and
follow-up
Patient
records
Age, Sex
Fracture location: Lawrence and Botte type I and II [3]
Fracture characteristics: Number of fragments, displacement,
articular involvement
Complications
Return to work
Return to sports
Radiographic follow-up (when available)
Follow-up VAS-FA [6]
SF-12v2
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grouped into three categories (function, pain, other com-
plaints) [7, 8]. Score values for the overall and subgroup
scores range between 0 and 100 points, with higher
scores indicating a better outcome. The SF-12 score was
analysed using the manufactures analytic tool-box (li-
cense number QM027870). The SF-12v2 is a short ver-
sion of the SF-36 Health Survey, measuring eight
domains. These are consolidated into two meta-scores:
The Mental Component Summary (MCS) and the Phys-
ical Component Summary (PCS). The MCS and PCS
scores range between 0 to 100, with a score of 50 being
representative for a sample population.
Data analysis and statistics
Data analysis was conducted to assess the influence of
(1) the fracture location (L&B type I vs. II) and (2) the
fracture characteristics (displacement, intra-articular
involvement, and number of fragments) on the outcome
variables outlined above. Statistics applied were standard
descriptive statistics, independent T-tests, and Chi-
Square-test, were appropriate. Furthermore, the influ-
ence of the fracture classification and characteristics
(independent variables) on the outcome parameters
(dependent variable) were assessed using a linear regres-
sion model (Enter Method). Results are indicated as
means ± standard deviation (SD). Due to multiple test-
ing, an alpha-level correction (Bonferroni) was con-
ducted (p < 0.007). Statistics were computed using SPSS
Vs. 21 (IBM Company).
Results
Fracture classification and characteristics
The left proximal MTV was fractured in 49%. Lawrence
and Botte type I fractures occurred in 59% of the patients.
Out of all fractures, 31% were dislocated (>2 mm), 74%
intra-articular, and 41% multi-fragmentary (Table 3).
Intra-articular fractures (fifth metatarso-cuboid joint)
occurred significantly more often in L&B type I com-
pared to type II fractures (p = 0.004). No significant
differences were observed for displacement or number
of fragments between both fracture types. No signifi-
cant age, side, or gender differences were found for
any of these parameters.
Treatment details
All patients were treated according to the regimen out-
lined above. Twenty-eight percent of patients bore
weight fully in a hard-soled shoe immediately. The
remaining patients were temporarily immobilized for a
maximum of 2 weeks (cast: 8%, walking boot: 54%, short
walking boot: 10%). The mean number of follow-up
visits at our outpatient clinic was 1.3 ± 1.6 (range: 0–6).
This figure does not include the final follow up visit,
which was conducted to assess the mid-term results.
Outcome
The mean follow-up was 22 ± 10 month (6–40 month).
The patients returned to work after 17 ± 12 days (range:
0–56 days), and to previous sports levels after 53 ±
22 days (range: 21–100) on average. At final follow-up,
the overall VAS-FA score was 96 ± 4, the subscale pain
95 ± 7, and the subscale function 97 ± 4. The mean SF-
12 PCS score was 57 ± 5 and the MCS score 51 ± 8. No
complications were reported, no patient required sur-
gery. Seven patients (18%) suffered symptoms after 6
weeks. Only these patients received a radiographic
follow-up. All these follow-up radiographs were unsuspi-
cious, showing bony union in all cases. Patients receiving
follow-up radiographs did not differ in any respect (frac-
ture location, −characteristics, or outcome variables) to
those with no follow-up radiographs. No complications
were identified.
Influence of fracture location
The above outlined outcome variables (return to work,
return to sports, VAS-FA, SF-12) were analysed separ-
ately for each fracture location (L&B type I and II). An
independent students t-test revealed no significant dif-
ference for these outcome variables between the two
fracture locations (Table 4). The linear regression model
also proofed no significant influence of the fracture loca-
tion on any of the outcome parameters.
Influence of fracture characteristics
A similar analysis was conducted to assess the influence
of the fracture characteristics (displacement, intra-
articular involvement, and number of fragments) on all
outcome variables (Table 5). None of the fracture char-
acteristics individually had a significant influence on any
of the outcome parameters. Similar, the linear regression
model showed no significant effect of the fracture char-
acteristics on the outcome scores.
Discussion
Whereas there is a broad consensus on functional treat-
ment for non-displaced L&B type I fractures, limited evi-
dence is available for the best treatment for L&B type II
fractures [9–17]. Today, few studies report promising
Table 3 Fracture characteristics per L&B Zone I and II fractures
Number Dislocated Intra-articular Multi-fragmentary
Total 39 31% 74% 41%
L&B type I 23 (59%) 26% 91% 39%
L&B type II 16 (41%) 38% 50% 44%
p-value 0.447 0.004 0.773
L&B Lawrence and Botte
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results following functional treatment while other au-
thors argue for operative treatment [18–21]. A major
reason for these conflicting recommendations is the in-
consistent use of the term “Jones fracture” for both L&B
type II and III fractures [22–24]. An example for the
confusion resulting from this lack of definition is the
systematic review by Roche et al. [25], analysing the out-
come of “Jones fractures” in 26 studies. When looking at
these studies in detail, the great majority analysed L&B
type III fractures. Some did not clearly define the frac-
ture types and only one study clearly included L&B type
II fractures. In consequence, the actual treatment rec-
ommendation for type II fractures remains unclear.
In the herein presented study, early functional treat-
ment of all L&B type I and II fractures lead to excellent
results (Tbl. 4). Both, return to work and sports were
comparable to previous studies including L&B type I
fractures only [12, 14, 16, 26]. The mean foot specific
outcome score (VAS-FA) for all fractures was similar to
healthy individuals (94.5 ± 8.2 Points) [27]. The partici-
pants’ quality of life scores (SF-12: PCS and MCS) were
slightly higher than the populations’ average. Finally, our
treatment regimen did not result in any complications
or conversion of treatment. When comparing L&B type
I and II fractures no significant differences could be de-
tected for any outcome parameter within a follow-up of
22 ± 10 months.
The few studies available for type II fractures demon-
strated comparable results to the herein presented
findings. Still they are inherent of shortcomings that
need to be discussed. Bigsby et al. [19] reported on the
outcome of 62 type I and 26 type II fractures. No differ-
ences were found for the Foot Function Index (FFI) and
the Short Form 36 between type I and II fractures. Un-
fortunately, no standardized treatment regimen was ap-
plied. Konkel et al. [28] treated 35 type I and 10 type II
fractures nonoperatively. Treatment varied from no
treatment to immobilization in a short leg cast. In aver-
age patients required 3.5 months to resume full duty.
The orthesis, cast or shoe was applied for a minimum of
6 weeks. This long immobilization might have contrib-
uted to the prolonged time of recovery. Nevertheless,
100% of the patients were satisfied with the result. Van
Aaken et al. [18] applied functional treatment for 15
type I and 8 type II fractures with an elastic dressing.
The mean time to return to work was 21 days for pa-
tients with type I fractures compared to surprisingly
4 days for patients with type II fractures. Taken to-
gether, type II fractures can be treated functionally
with an excellent clinical outcome, comparable to
L&B type I fractures.
Further, many authors postulate that displaced (>2 mm),
multifragmentary, or intra-articular fractures necessitate
operative treatment. Almost all of these recommendations
are solely based on the authors’ opinion, but not on evi-
dence [3, 10, 29–33]. Therefore, the second aim of this
study was to evaluate the influence of these aspects on the
outcome of functionally treated L&B type I and II
Table 4 Fracture type and outcome variables at final follow-up
Return to work [d] Return to sports [d] VAS Overall VAS Pain VAS Function SF-12 PCS SF-12 MCS
Total 17 ± 12 53 ± 22 96 ± 4 95 ± 7 97 ± 4 57 ± 5 51 ± 8
L&B type I 15 ± 10 47 ± 19 97 ± 3 96 ± 6 98 ± 3 58 ± 3 51 ± 7
L&B type II 20 ± 15 63 ± 25 95 ± 4 92 ± 7 96 ± 5 55 ± 7 51 ± 9
p-value 0.194 0.040 0.098 0.051 0.069 0.133 0.915
d days, L&B Lawrence and Botte [3], VAS VAS-FA [6], SF-12 PCS SF-12 Physical Health Composite Scores, SF-12 MCS Mental Health Composite Scores
Table 5 Fracture characteristics and outcome parameters at final follow-up
Return to work [d] Return to sports [d] VAS Overall VAS Pain VAS Function SF-12 PCS SF-12 MCS
Total 17 ± 12 53 ± 22 96 ± 4 95 ± 7 97 ± 4 57 ± 5 51 ± 8
Non-dislocated 18 ± 12 51 ± 23 96 ± 4 95 ± 7 97 ± 4 56 ± 6 51 ± 7
Dislocated 15 ± 12 57 ± 22 97 ± 3 95 ± 7 98 ± 3 58 ± 3 51 ± 9
p-value 0.502 0.536 0.323 0.987 0.439 0.220 0.876
Extra-articular 17 ± 13 60 ± 28 95 ± 5 92 ± 9 96 ± 5 56 ± 6 50 ± 11
Intra-articular 17 ± 12 51 ± 20 97 ± 3 96 ± 6 98 ± 4 57 ± 5 52 ± 6
p-value 0.970 0.343 0.340 0.202 0.275 0.546 0.604
Two fragments 16 ± 10 52 ± 25 96 ± 4 95 ± 7 97 ± 4 56 ± 4 53 ± 8
Multi fragmentary 18 ± 15 54 ± 20 96 ± 4 95 ± 7 97 ± 4 57 ± 7 49 ± 8
p-value 0.682 0.833 0.991 0.971 0.835 0.760 0.214
d days, VAS VAS-FA [6], SF-12 PCS SF-12 Physical Health Composite Scores, SF-12 MCS SF-12 Mental Health Composite Scores
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fractures. None of the fracture characteristics analysed,
namely fracture displacement greater 2 mm, articular in-
volvement, or comminution, affected any of the outcome
parameters assessed.
To the authors’ knowledge, only two studies report
data regarding the impact of intra-articular involvement
and displacement on the clinical outcome [16, 17]. Egol
et al. [16] treated L&B type I fractures by immediate
weightbearing as tolerated. Out of these, 50% were intra-
articular and 32% displaced (>2 mm). The average time
to return to work was 22 days. Comparing intra- to
extra-articular fractures and non-displaced to displaced
fractures, no significant differences could be observed
for any of the outcome parameters (SMFA pain, VAS).
Tahririan et al. [17] treated 143 patients with a fracture
to the base of the fifth metatarsal (L&B type I, II, III)
with a short leg cast for 6 weeks. The average AOFAS
score after 20 weeks for all fractures was 93 with a 95%
confidence interval of 92–94. The multivariate analysis
revealed that displacement, patient weight, type III frac-
tures, diabetes and female gender were associated with a
poorer AOFAS. One should keep in mind, that the
AOFAS score, the only outcome parameter assessed, has
been proven to be poorly valid and the minimal import-
ant clinical difference of this score is unknown [34].
Moreover, the average AOFAS in this study was ex-
tremely high with a remarkably narrow CI suggesting an
excellent outcome for all fractures. Finally, the results of
the statistical analysis are not comprehensible, as the au-
thors did not present any data in detail. All in all, the
data presented in our study argue for functional treat-
ment of all L&B type I and II fractures, independent of
displacement, articular involvement, or comminution.
Several limitations and strengths have to be discussed.
First, the most pronounced limitation is the initial retro-
spective data assessment. Second, the final follow-up
rate is limited to 41%. Consequently, it is unclear what
happened to the patients lost to follow up, whether they
received surgery elsewhere, suffered inferior clinical re-
sults or were in line with the patients included in this
study. Still, this follow-up rate is compare to previous
studies [35–37]. Third, patient specific factors such as
intrinsic bone disorders or metabolic disorders were not
assessed. Fourth, despite a mean follow-up of almost 2
years, refractures have been reported to occur even after
that time range [38]. Still, most recent studies report low
re-fracture rates in operatively treated patients initially
suffering a stress fracture (L&B type III) [39] or athletes
[21, 38, 40]. The risk for re-fracture after conservative
treatment for L&B type I and II fractures remains un-
known. A final limitation could be, a missing radio-
graphic follow up for all patients. In accordance with
literature, radiographic follow up was only conducted in
case of prolonged symptoms of more than 6 weeks. In
these patients, no non-union was observed. Still, asymp-
tomatic non-unions could have been missed. As an
asymptomatic non-union does not require any further
treatment the authors would not consider this a compli-
cation. Therefore, we are convinced, that the missing
radiographic follow-up of asymptomatic patients should
not be considered a limitation. Contrariwise, this regime
drastically reduces the number of follow-up visits.
Strengths of this study were the use of two validated
patient rated outcome measures, one specific for foot
and ankle disorders, the other a commonly used quality
of life score [6, 27]. Furthermore, the fracture character-
istics were assessed by two independent investigators
and a mean, prospective follow up of almost 2 years was
reached. Finally, a detailed workup of various factors
possibly influencing the results was presented.
Conclusions
In conclusion, functional treatment leads to excellent
clinical results for both, L&B type I and type II fractures.
(1) As both fracture locations did not differ for outcome,
they should not be delineated, but rather be summarized
as epi-metaphyseal. (2) Fracture displacement greater
2 mm, intra-articular involvement, and comminution
did not affect the outcome. Therefore, functional treat-
ment should be applied to all epi-metaphyseal fractures,
even when displaced, intra-articular or comminuted.
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